Analysis of the Influence of Serum MMP-2 and vWF Levels on the Predictive Value of Risk Grade and Prognosis of Patients with Acute Myeloid Leukemia

Table 1

The change in the expression levels of MMP-2 in the three groups (‾x ± s, ng/mL).

Group	Pretherapy	Posttreatment
A group (n = 32)	413.45 ± 59.23	211.56 ± 41.22
B group (n = 46)	431.55 ± 65.41^a	232.44 ± 53.41^a
C group (n = 27)	463.36 ± 54.32^ab	255.43 ± 47.63^ab
F	21.231	20.143
	<0.001	<0.001